{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:06:24Z","timestamp":1791227184503,"version":"4.1.0"},"reference-count":101,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2011,9,1]],"date-time":"2011-09-01T00:00:00Z","timestamp":1314835200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2011,9]]},"DOI":"10.1016\/j.ejphar.2011.07.008","type":"journal-article","created":{"date-parts":[[2011,7,29]],"date-time":"2011-07-29T14:32:14Z","timestamp":1311949934000},"page":"S2-S9","source":"Crossref","is-referenced-by-count":95,"special_numbering":"S1","title":["Functional foods and dietary supplements: Products at the interface between pharma and nutrition"],"prefix":"10.1016","volume":"668","author":[{"given":"Simone R.B.M.","family":"Eussen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Verhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olaf H.","family":"Klungel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Garssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk","family":"van Loveren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henk J.","family":"van Kranen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy J.M.","family":"Rompelberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.07.008_bb0005","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2174\/138920010791110818","article-title":"An update on drug interactions with the herbal medicine Ginkgo biloba","volume":"11","author":"Abad","year":"2010","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0010","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jada.2006.01.001","article-title":"Nutrigenomics: from molecular nutrition to prevention of disease","volume":"106","author":"Afman","year":"2006","journal-title":"J. Am. Diet. Assoc."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0015","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s10557-007-6015-5","article-title":"Advertising campaigns of sterol-enriched food. An often neglected cause of reduced compliance to lipid lowering drug therapy.","volume":"21","author":"Alevizos","year":"2007","journal-title":"Cardiovasc. Drugs Ther."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0020","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1163\/157180909X437123","article-title":"ECJ 2009\/02 Hecht-Pharma GmbH v. Staatliches Gewerbeaufsichtsamt L\u00fcneburg and Vertreterin des Bundesinteresses beim Bundesverwaltungsgericht, 15 January 2009 (C-140\/07)","volume":"16","author":"Baeyens","year":"2009","journal-title":"Eur. J. Health Law"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0025","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1753-4887.1999.tb01815.x","article-title":"Vitamin K: a practical guide to the dietary management of patients on warfarin","volume":"57","author":"Booth","year":"1999","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0030","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S0031-6997(25)00027-4","article-title":"Pharmacology of cyclosporine (sandimmune). I. Introduction.","volume":"41","author":"Borel","year":"1990","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0035","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1208\/s12248-009-9146-8","article-title":"Herb-drug interactions with St John's wort (Hypericum perforatum): an update on clinical observations","volume":"11","author":"Borrelli","year":"2009","journal-title":"AAPS J."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0040","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/0002-9149(94)90307-7","article-title":"Expanded Clinical Evaluation of Lovastatin (EXCEL) study results: two-year efficacy and safety follow-up","volume":"74","author":"Bradford","year":"1994","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0045","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/01.CIR.58.1.164","article-title":"Decreased bioavailability of digoxin due to hypocholesterolemic interventions","volume":"58","author":"Brown","year":"1978","journal-title":"Circulation"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0050","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/j.1365-2796.2008.01933.x","article-title":"Combination therapy in the management of mixed dyslipidaemia","volume":"263","author":"Cannon","year":"2008","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0055","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev-med-011209-132719","article-title":"Using genetic diagnosis to determine individual therapeutic utility","volume":"61","author":"Caskey","year":"2010","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0060","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.phrs.2010.04.001","article-title":"Herbal interactions on absorption of drugs: mechanisms of action and clinical risk assessment","volume":"62","author":"Colalto","year":"2010","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0065","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1159\/000098146","article-title":"Use of botanicals in food supplements. Regulatory scope, scientific risk assessment and claim substantiation","volume":"50","author":"Coppens","year":"2006","journal-title":"Ann. Nutr. Metab."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0070","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.tox.2005.12.022","article-title":"European regulations on nutraceuticals, dietary supplements and functional foods: a framework based on safety","volume":"221","author":"Coppens","year":"2006","journal-title":"Toxicology"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0075","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/sj.ejcn.1601736","article-title":"Food-drug interaction: grapefruit juice augments drug bioavailability-mechanism, extent and relevance","volume":"58","author":"Dahan","year":"2004","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0080","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1136\/bmj.39196.666377.BE","article-title":"Functional foods: the case for closer evaluation","volume":"334","author":"de Jong","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0085","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tifs.2008.05.001","article-title":"A general postlaunch monitoring framework for functional foods tested with the phytosterol\/-stanol case","volume":"19","author":"de Jong","year":"2008","journal-title":"Trends Food Sci. Technol."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0090","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0095","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0100","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0105","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0110","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0115","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0120","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0125","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0130","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0135","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0140","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0145","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0150","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0155","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0160","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0165","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0170","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0175","author":"EFSA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0180","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.atherosclerosissup.2004.08.033","article-title":"The origin of the statins. 2004","volume":"5","author":"Endo","year":"2004","journal-title":"Atheroscler. Suppl."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2011.07.008_bb0185","first-page":"S1","article-title":"Scientific concepts of functional foods in Europe. Consensus document.","volume":"81","author":"Europe","year":"1999","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0190","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0195","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0200","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0205","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0210","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0215","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0220","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0225","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0230","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0235","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0240","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0245","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0250","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0255","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0260","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0265","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0270","author":"European Commission"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0275","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1017\/S0007114509993230","article-title":"Support of drug therapy using functional foods and dietary supplements: focus on statin therapy","volume":"103","author":"Eussen","year":"2010","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0280","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/pds.2042","article-title":"Effects of the use of phytosterol\/-stanol-enriched margarines on adherence to statin therapy","volume":"19","author":"Eussen","year":"2010","journal-title":"Pharmacoepidemiol. Drug Saf."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0505","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.phrs.2011.02.008","article-title":"Simultaneous intake of oat bran and atorvastatin reduces their efficacy to lower lipid levels and atherosclerosis in LDLr-\/- mice","volume":"64","author":"Eussen","year":"2011","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0285","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.amjmed.2003.12.036","article-title":"Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols","volume":"116","author":"Franco","year":"2004","journal-title":"Am. J. Med."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0290","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1111\/j.1539-6924.2009.01350.x","article-title":"A tiered approach for risk-benefit assessment of foods","volume":"30","author":"Fransen","year":"2010","journal-title":"Risk anal."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0295","doi-asserted-by":"crossref","first-page":"2382S","DOI":"10.1093\/jn\/132.8.2382S","article-title":"Gene-nutrient interactions and DNA methylation","volume":"132","author":"Friso","year":"2002","journal-title":"J. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0300","doi-asserted-by":"crossref","first-page":"981","DOI":"10.2165\/11537590-000000000-00000","article-title":"Evaluation of benefit\u2013risk","volume":"28","author":"Garattini","year":"2010","journal-title":"PharmacoEconomics"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0305","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1038\/ejcn.2010.101","article-title":"Functional foods","volume":"64","author":"Henry","year":"2010","journal-title":"Eur. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0310","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.fct.2007.09.008","article-title":"The application of post-market monitoring to novel foods","volume":"46","author":"Hepburn","year":"2008","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0315","article-title":"BRAFO tiered approach for benefit\u2013risk assessment of foods","author":"Hoekstra","year":"2010","journal-title":"Food Chem. Toxicol"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0320","article-title":"Functional Foods From Science to Health and Claims","volume":"1\u201336","author":"Howlett","year":"2008","journal-title":"ILSI Eur. Concise Monogr. Ser."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0325","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/BF00630301","article-title":"Effect of guar gum, a fibre preparation, on digoxin and penicillin absorption in man","volume":"26","author":"Huupponen","year":"1984","journal-title":"Eur. J. Clin. Pharmacol."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0330","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.copbio.2008.02.005","article-title":"Nutrigenomics research for personalized nutrition and medicine","volume":"19","author":"Kaput","year":"2008","journal-title":"Curr. Opin. Biotechnol."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0335","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1126\/science.1078638","article-title":"Public health. Toward evidence-based health claims for foods.","volume":"299","author":"Katan","year":"2003","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0340","doi-asserted-by":"crossref","first-page":"965","DOI":"10.4065\/78.8.965","article-title":"Efficacy and safety of plant stanols and sterols in the management of blood cholesterol levels","volume":"78","author":"Katan","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0345","author":"Kotilainen"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0350","doi-asserted-by":"crossref","first-page":"447","DOI":"10.2217\/17410541.5.5.447","article-title":"Nutrigenomics and personalized nutrition: science and concept","volume":"5","author":"Kussmann","year":"2008","journal-title":"Pers. Med."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0355","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1331\/JAPhA.2010.09124","article-title":"Pharmacogenomics: bridging the gap between science and practice","volume":"50","author":"Lee","year":"2010","journal-title":"J. Am. Pharm. Assoc."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0360","first-page":"340","article-title":"Discovery of salicine","volume":"6","author":"Leroux","year":"1830","journal-title":"J. Chim. Med."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0365","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3233\/JRS-2005-337","article-title":"Four decades of European medicines regulation: what have they brought us?","volume":"17","author":"Lisman","year":"2005","journal-title":"Int. J. Risk Saf. Med."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0370","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1365-2184.2006.00377.x","article-title":"The historical analysis of aspirin discovery, its relation to the willow tree and antiproliferative and anticancer potential","volume":"39","author":"Mahdi","year":"2006","journal-title":"Cell Prolif."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0375","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1001\/jama.290.11.1500","article-title":"Effect of St John's wort on drug metabolism by induction of cytochrome P450 3A4 enzyme","volume":"290","author":"Markowitz","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0380","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2165\/00003495-199957060-00003","article-title":"Antacids revisited: a review of their clinical pharmacology and recommended therapeutic use","volume":"57","author":"Maton","year":"1999","journal-title":"Drugs"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0385","doi-asserted-by":"crossref","first-page":"1654S","DOI":"10.1093\/ajcn\/71.6.1654S","article-title":"Functional foods: the US perspective","volume":"71","author":"Milner","year":"2000","journal-title":"Am. J. Clin. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0390","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1517\/17460441.1.6.549","article-title":"Anthracyclines as effective anticancer drugs","volume":"1","author":"Nadas","year":"2006","journal-title":"Expert Opin. Drug Discovery"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0395","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1177\/0091270002424013","article-title":"Lack of bioequivalence of ciprofloxacin when administered with calcium-fortified orange juice: a new twist on an old interaction","volume":"42","author":"Neuhofel","year":"2002","journal-title":"J. Clin. Pharmacol."},{"issue":"Suppl 1","key":"10.1016\/j.ejphar.2011.07.008_bb0400","doi-asserted-by":"crossref","first-page":"S33","DOI":"10.1007\/s00394-009-0074-2","article-title":"Safety impact\u2013the risk\/benefits of functional foods","volume":"48","author":"Pascal","year":"2009","journal-title":"Eur. J. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0405","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.atherosclerosis.2005.10.026","article-title":"Phytosterols and vascular disease","volume":"186","author":"Patel","year":"2006","journal-title":"Atherosclerosis"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0410","author":"Personalized Medicine Coalition"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0415","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1161\/HYPERTENSIONAHA.107.086900","article-title":"Molecular genetics of experimental hypertension and the metabolic syndrome: from gene pathways to new therapies","volume":"49","author":"Pravenec","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0420","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/0140-6736(91)91291-2","article-title":"Interaction between fibre and lovastatin","volume":"338","author":"Richter","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0425","first-page":"1","article-title":"Dietary vitamin K intake and anticoagulation in elderly patients","volume":"10","author":"Rohde","year":"2007","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0430","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00003088-200746020-00001","article-title":"Drug-drug and food-drug pharmacokinetic interactions with new insulinotropic agents repaglinide and nateglinide","volume":"46","author":"Scheen","year":"2007","journal-title":"Clin. Pharmacokinet."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0435","doi-asserted-by":"crossref","first-page":"750-750","DOI":"10.1001\/jama.279.10.750-b","article-title":"Calcium carbonate and reduction of levothyroxine efficacy","volume":"279","author":"Schneyer","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0440","series-title":"The European regulation of food supplements and food fortification","author":"Schwitters","year":"2007"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0445","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1017\/S2071832200013201","article-title":"Risk assessment in the European Food Safety Regulation: who is to decide whose science is better? Commission v. France and Beyond\u2026","volume":"5","author":"Szawlowska","year":"2001","journal-title":"Ger. Law J."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0450","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1753-4887.2004.tb00024.x","article-title":"Regulatory frameworks for functional foods and dietary supplements","volume":"62","author":"Taylor","year":"2004","journal-title":"Nutr. Rev."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0455","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1136\/bmj.329.7472.972","article-title":"Inclusion of cost effectiveness in licensing requirements of new drugs: the fourth hurdle","volume":"329","author":"Taylor","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0500","series-title":"State of the art in benefit-risk analysis: food and nutrition","author":"Tijhuis","year":"2011"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0460","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0465","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0470","author":"U.S. Food and Drug Administration"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0475","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.2174\/138920008786927785","article-title":"Clinical evidence of herb-drug interactions: a systematic review by the natural standard research collaboration","volume":"9","author":"Ulbricht","year":"2008","journal-title":"Curr. Drug Metab."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0480","series-title":"Our food, our health: healthy diet and safe food in the Netherlands","first-page":"189","author":"van Kreijl","year":"2006"},{"key":"10.1016\/j.ejphar.2011.07.008_bb0485","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1017\/S0007114508184690","article-title":"Novel foods: an explorative study into their grey area","volume":"101","author":"Verhagen","year":"2009","journal-title":"Br. J. Nutr."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0490","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.abb.2010.04.012","article-title":"Status of nutrition and health claims in Europe","volume":"501","author":"Verhagen","year":"2010","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejphar.2011.07.008_bb0495","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1177\/0091270002239711","article-title":"Lack of bioequivalence of gatifloxacin when coadministered with calcium-fortified orange juice in healthy volunteers","volume":"43","author":"Wallace","year":"2003","journal-title":"J. Clin. Pharmacol."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911007795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911007795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,7]],"date-time":"2025-03-07T22:29:11Z","timestamp":1741386551000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911007795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,9]]},"references-count":101,"alternative-id":["S0014299911007795"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.07.008","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2011,9]]}}}